Source briefing
Fifth European Medicines Agency (EMA) and Affordable Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 11 September 2026
Fifth European Medicines Agency (EMA) and Affordable Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 11 September 2026
Read →
Source briefing
European platform for regulatory science research meeting: October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2026, 09:00 (CEST) to 22 October 2026, 17:00 (CEST)
European platform for regulatory science research meeting: October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2026, 09:00 (CEST) to 22 October 2026, 17:00 (CEST)
Read →Source briefing
Communicable disease threats report, 27 – 31 July 2026, week 31
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 - 31 July 2026, and includes updates on Ebola, West Nile Virus infections, Crimean-Congo haemorrhagic fever, dengue, avian influenza A(H9N2), expert deployment, cholera, chikungunya…
Read →
Source briefing
Ex-Chief of Staff for Malta’s Former Prime Minister Testifies Against Childhood Friend Accused of Ordering Journalist’s Murder
Keith Schembri served as chief of staff to Malta’s prime minister at the time investigative journalist Daphne Caruana Galizia was assassinated. He testified this week that the killing was commissioned by businessman Yorgen Fenech, who is on trial.…
Read →Source briefing
Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 14, Status: Authorised
Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 14, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Multaq, dronedarone, Date of authorisation: 25/11/2009, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Multaq, dronedarone, Date of authorisation: 25/11/2009, Revision: 23, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 33, Status: Authorised
Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tezacaftor,elexacaftor, Date of authorisation: 21/08/2020, Revision: 33, Status: Authorised
Read →Source briefing
New leadership team appointments
EMA’s Head of the Stakeholders…, A new Head of the Veterinary…, Ivo Claassen joined EMA in 2018. Among many career highlights, Ivo and his team worked with the veterinary medicines network on the successful implementation of the 2019…
Read →Source briefing
Human medicines European public assessment report (EPAR): Boey, trenibotulinumtoxinE, Date of authorisation: 15/07/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Boey, trenibotulinumtoxinE, Date of authorisation: 15/07/2026, Status: Authorised
Read →Source briefing
Human medicines European public assessment report (EPAR): Jascayd, nerandomilast, Date of authorisation: 15/07/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Jascayd, nerandomilast, Date of authorisation: 15/07/2026, Status: Authorised
Read →